toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Sareddy, G. R., Viswanadhapalli, S., Surapaneni, P., Suzuki, T., Brenner, A., & Vadlamudi, R. K. (2017). Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway. Oncogene, 36(17), 2423–2434.
toggle visibility
Clark, P. A., Gaal, J. T., Strebe, J. K., Pasch, C. A., Deming, D. A., Kuo, J. S., et al. (2017). The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells. J Clin Neurosci, 36, 120–124.
toggle visibility
Jin, W. - L., Mao, X. - Y., & Qiu, G. - Z. (2017). Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges. Med Res Rev, 37(3), 627–661.
toggle visibility
Nourallah, B., Digpal, R., Jena, R., & Watts, C. (2017). Irradiating the Subventricular Zone in Glioblastoma Patients: Is there a Case for a Clinical Trial? Clin Oncol (R Coll Radiol), 29(1), 26–33.
toggle visibility
Luedi, M. M., Singh, S. K., Mosley, J. C., Hatami, M., Gumin, J., Sulman, E. P., et al. (2017). A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol, 29(1), 46–58.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print